Zendo
Zendo, operated by Bodhi NeuroTech, Inc. in Charleston, SC, sells a $119 tDCS neurostimulation headband direct-to-consumer to help individual users reach meditative states faster in 20-minute sessions, with recurring revenue from consumable saline pads.
- Company typePrivate
- Founded-
- HeadquartersCharleston, United States
- Headcount—
- GTM typeB2C
- OfferingHardware or Manufacturing
What Zendo does
Zendo is a direct-to-consumer neurotech wellness brand operated by Bodhi NeuroTech, Inc., a privately held Charleston, SC corporation founded by neuroscientist Bashar Badran, PhD and psychiatrist Baron Short, MD. Its sole commercial product is the Zendo Meditation Headband, a wearable that delivers low-level transcranial direct current stimulation (tDCS) to the prefrontal cortex via saline pads over 20-minute sessions, with the intent of accelerating entry into meditative states. The technology is derived from the co-founders' E-Meditation research at the Medical University of South Carolina, including a double-blind, sham-controlled study published in Brain Stimulation.
The business sells exclusively through its owned storefront at zendomeditation.com. The headband is priced at $119 as a one-time purchase with no subscription; a $14.99 refill pack of ten single-use saline pads (~$0.60 per session) creates a modest recurring consumables stream on the installed base. An optional companion app provides guided content, but the device operates standalone without a phone. The company positions itself as a general wellness product rather than a medical device, competing on price and accessibility against prescription tDCS systems (Flow) and EEG-only wearables (Muse, Flowtime).
The customer base is entirely individual consumers spanning general wellness, meditation practitioners, sleep seekers, and focus/productivity users, with no enterprise or institutional accounts disclosed. Marketing relies on earned media (New Scientist, Women's Health, Vox), an email newsletter with a first-order discount, and website content marketing. Scale evidence is limited — 40+ verified owners and a 4.7-star average review — and there are no disclosed funding rounds, headcount figures, or revenue figures in the available material.
Zendo firmographics
Firmographics- Name
- Zendo
- Legal name
- Bodhi NeuroTech, Inc.
- Website
- https://zendomeditation.com
- Company type
- Private
- Operating status
- Operating
- Short description
- Zendo, operated by Bodhi NeuroTech, Inc. in Charleston, SC, sells a $119 tDCS neurostimulation headband direct-to-consumer to help individual users reach meditative states faster in 20-minute sessions, with recurring revenue from consumable saline pads.
- Ownership category
- akta.pro rank
Zendo industry classification
Industry- Product category
- Consumer Neurostimulation Wearables
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL)
Keywords
Where Zendo is headquartered
LocationHeadquarters
- HQ city
- Charleston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Zendo business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Technology or R&D, Operations, Personnel, Others
Revenue model
- Hardware Sales (Headband): One-time purchase of the Zendo headband device at $119. The headband is reusable and rechargeable, containing all stimulation technology. This represents the primary revenue stream for initial customer acquisition.
- Consumables (Saline Pads): Recurring purchase of single-use saline pads required for each session. Pads are sold in 10-packs for $14.99. Each session uses one fresh pad. This creates an ongoing revenue stream from the installed customer base, with approximately 60 cents per session cost in the first year.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Zendo Meditation Headband - One-time purchase |
| Unit Pricing | Pay-as-you-go | Zendo Pads Refill Pack |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Zendo product offering
Product offeringCore offering
Zendo sells a reusable, rechargeable tDCS neurostimulation headband (priced at $119 one-time) that delivers a low-level electrical current through saline pads placed on the forehead over the prefrontal cortex to help users reach calmer, more focused mental states within 20-minute sessions. The headband operates standalone without a smartphone app and ships with 20 single-use saline pads; recurring consumable pad refills (10-packs at $14.99) generate ongoing revenue from the installed customer base.
Product overview
Zendo offers a neurotech wellness system centered on its Zendo Meditation Headband, a hardware device that uses gentle tDCS-style transcranial direct current stimulation applied to the prefrontal cortex to help users settle into meditative states faster. The core headband ($119, reusable and rechargeable) works standalone or pairs with the companion Zendo App for optional guided meditation. Consumable saline pads (10-pack for $14.99, with 20 included at purchase) are required for each 20-minute session. The company positions Zendo as a general wellness product, not a medical device.
Differentiator
Problem solved
Functional benefit
Products and services
- Zendo Meditation Headband A reusable, rechargeable headband that delivers gentle tDCS-style neurostimulation to the prefrontal cortex via saline pads on the forehead, designed to help individual adult consumers settle into calmer, more focused mental states inside a 20-minute session without requiring an app or years of meditation practice.
- Zendo Pads (Refill 10-Pack) Single-use saline pads designed for the Zendo Meditation Headband; one fresh pad is required per 20-minute session for optimal electrical conductivity and stimulation delivery.
Quantifiable outcome
- Significant gains in mindfulness measures relative to sham in double-blind clinical study
- +3 more outcomes
Companies that use Zendo
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Zendo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Zendo partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Medical University of South Carolina (MUSC)coreThe founders conducted E-Meditation research at MUSC, including a double-blind, sham-controlled study published in Brain Stimulation journal. This research formed the scientific foundation for Zendo's tDCS technology. Co-founders Bashar Badran, PhD (Associate Professor of Psychiatry and Founding Director of Neuro-X Lab) and Baron Short, MD (Psychiatrist and Professor, Medical Director of MUSC Brain Stimulation Service) maintain their academic affiliations while commercializing the technology through Bodhi Neurotech.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Zendo competitors and assessment
Company assessmentEmerging players
- Lief Therapeutics: Lief sells a heart-rate-variability biofeedback patch for stress regulation and emotional resilience. Comparable to Zendo as a discreet, wearable consumer neuro-wellness device for daily calm and stress management.
- Sensate: Sensate is a bone-conduction vagus nerve stimulation device for stress and calm. Comparable to Zendo as a consumer neurostimulation wellness product targeting the same stress/relaxation outcome through a different stimulation modality.
- Hapbee Technologies: Hapbee sells a wearable that delivers low-power electromagnetic fields to mimic substances (caffeine, melatonin, calm). Comparable to Zendo as a consumer neuro-wellness hardware targeting mood, calm, focus, and sleep outcomes without prescription.
- Cove (previously Cala Health): Cove (formerly Cala Trio) sells a non-invasive brain stimulation wearable, originally FDA-cleared for essential tremor. Comparable to Zendo as a consumer-facing neurostimulation wearable entering adjacent wellness categories.
- Apollo Neuro: Apollo Neuro sells a wearable that uses low-frequency vibration to calm the nervous system for stress, focus, and sleep. Comparable to Zendo as a non-invasive neuro-wellness consumer device targeting stress and sleep without an app requirement.
Broad incumbents
- Calm: Calm is a leading meditation and sleep app with broad mainstream reach and celebrity-driven brand. Competes with Zendo for the meditation and sleep-seeking consumer, offering an app-only alternative to the headband category.
- Headspace: Headspace is the largest consumer meditation app with millions of subscribers and a household brand in mindfulness. Competes with Zendo for the same meditation-curious consumer wallet, but delivers guidance via audio rather than hardware-driven stimulation.
Direct peers
- Muse (Interaxon): Muse is the leading consumer EEG brain-sensing headband for meditation and sleep, priced $295-475. Competes with Zendo in the meditation headband category but uses biofeedback rather than stimulation and requires an app + subscription.
- Flowtime (Urgostem): Flowtime is a lower-priced EEG biofeedback headband priced under $200 for meditation tracking. Competes with Zendo as a meditation headband alternative for budget-conscious consumers who want neurofeedback without subscription fees.
- Flow (Flow Neuroscience): Flow sells a tDCS headband for depression treatment, FDA-cleared and prescription-only in the US at $500-800. Direct head-to-head competitor with Zendo on stimulation modality but targets the medical depression pathway while Zendo targets everyday wellness consumers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Zendo social profiles
Digital presenceZendo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zendo leadership team
Management profileNumber of profiles
Profiles2 records
Zendo funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zendo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zendo
What does Zendo do?
Zendo sells a reusable, rechargeable tDCS neurostimulation headband (priced at $119 one-time) that delivers a low-level electrical current through saline pads placed on the forehead over the prefrontal cortex to help users reach calmer, more focused mental states within 20-minute sessions. The headband operates standalone without a smartphone app and ships with 20 single-use saline pads; recurring consumable pad refills (10-packs at $14.99) generate ongoing revenue from the installed customer base.
Is Zendo a public or private company?
Zendo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Zendo founded?
Zendo was founded in -1.
Where is Zendo based?
Zendo is headquartered in Charleston, United States, in the North America region.
How does Zendo make money?
Two revenue lines are on record. Hardware Sales (Headband) is the primary driver. The others are consumables (Saline Pads).
Who are Zendo's main competitors?
Emerging players on record are Lief Therapeutics, Sensate, Hapbee Technologies, Cove (previously Cala Health) and Apollo Neuro. Broad incumbents are Calm and Headspace. Direct peers are Muse (Interaxon), Flowtime (Urgostem) and Flow (Flow Neuroscience).
Does Zendo have an API?
No public API is recorded for Zendo.
What industry is Zendo in?
Zendo's product category is Consumer Neurostimulation Wearables. Its primary akta.pro industry code is CRACAQAL, Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices). Its NAICS code is 334510 and its SIC code is 3845.